Related Experiment Videos
Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care
S J McClure1, L Caruana, A P Davie
1Department of Cardiology, Western Infirmary, Glasgow G11 6NT.
Insights
Blood natriuretic peptide levels do not effectively identify left ventricular systolic dysfunction in stable heart attack survivors. This study found these peptide concentrations are not useful for diagnosis in this patient group.
Area of Science:
- Cardiology
- Biomarkers
- Diagnostic Accuracy
Background:
- Left ventricular systolic dysfunction (LVSD) is a critical complication following myocardial infarction (MI).
- Accurate identification of LVSD is essential for guiding secondary prevention strategies in MI survivors.
- Non-invasive biomarkers could potentially aid in screening for LVSD.
Purpose of the Study:
- To evaluate the diagnostic utility of blood natriuretic peptide concentrations for identifying or excluding LVSD.
- To assess if natriuretic peptides can discriminate between different severities of LVSD in stable post-MI patients.
Main Methods:
- A comparative study involving 134 stable survivors of MI.
- Echocardiography was used to assess left ventricular systolic function.
- Blood concentrations of brain natriuretic peptide (BNP) and N-terminal atrial natriuretic peptide (NT-ANP) were measured.
- Receiver operating characteristic (ROC) curve analysis determined diagnostic performance.
Main Results:
- Brain natriuretic peptide showed limited diagnostic utility for severe LVSD (Area Under Curve [AUC] = 0.73).
- BNP could not differentiate between moderate/severe LVSD and preserved function (AUC = 0.54).
- N-terminal atrial natriuretic peptide demonstrated poor performance for both severe (AUC = 0.55) and moderate/severe LVSD (AUC = 0.56).
Conclusions:
- Blood natriuretic peptide concentrations are not clinically useful for identifying significant left ventricular systolic dysfunction in stable myocardial infarction survivors.
- Echocardiography remains the primary tool for assessing cardiac function in this population.
- Further research may explore other biomarkers or integrated approaches for LVSD detection post-MI.
Objectives:
To determine whether blood natriuretic peptide concentrations are helpful in identifying or excluding left ventricular systolic dysfunction in stable survivors of acute myocardial infarction.
Design:
Comparison of blood natriuretic peptide concentrations with echocardiographic assessment of left ventricular systolic function in a general practice population.
Setting:
Practices in Western District of Glasgow audit group.
Subjects:
134 long term survivors of myocardial infarction recalled for echocardiography as part of a primary care secondary prevention audit.
Main Outcome Measures:
Area under the receiver operating curve for brain natriuretic peptide and N-terminal atrial natriuretic peptide.
Results:
Brain natriuretic peptide was of some diagnostic utility in identifying the minority of subjects with severe left ventricular dysfunction (area under curve=0.73) but was unable to discriminate between patients with moderately severe dysfunction and those with preserved left ventricular function (area under curve for moderate or severe dysfunction=0.54). The corresponding values for N-terminal atrial natriuretic peptide for severe and moderate or severe dysfunction were 0.55 and 0.56 respectively.
Conclusions:
Blood natriuretic peptide concentrations are not useful in identifying important left ventricular systolic dysfunction in stable survivors of myocardial infarction.